# The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

> **NCT04214821** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National University of Malaysia** · enrollment: 128 (estimated)

## Conditions studied

- Endophthalmitis

## Interventions

- **DRUG:** Levofloxacin Ophthalmic Solution
- **DRUG:** Moxifloxacin Ophthalmic Solution

## Key facts

- **NCT ID:** NCT04214821
- **Lead sponsor:** National University of Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-23
- **Primary completion:** 2021-08
- **Final completion:** 2022-05
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2020-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04214821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04214821, "The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04214821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*